PharmiWeb.com - Global Pharma News & Resources
26-Jan-2026

Vetter Achieves Top Sustainability Rating and Expands Climate Goal Commitments

Vetter Achieves Top Sustainability Rating and Expands Climate Goal Commitments

Recent recognitions reinforce Vetter’s continued investment in renewable energy projects

  • Awarded EcoVadis Platinum rating for 2025
  • Received validation from Science Based Targets initiative (SBTi)
  • Renewable energy projects support ambitious sustainability strategy

Ravensburg, January 21, 2026: Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), has strengthened its sustainability strategy with distinguished recognitions: the internationally renowned EcoVadis Platinum rating as well as the official validation of its emission reduction targets by the Science Based Targets initiative (SBTi). Both achievements highlight the company’s commitment to climate protection and responsible business practices.

For the fourth consecutive year, Vetter has been recognized by the internationally renowned EcoVadis sustainability ranking, earning Platinum status for 2025 and placing itself among the top 1 percent of all rated companies globally.

The official validation of the emission reduction targets by the SBTi approves Vetter’s ambitious sustainability roadmap: by 2034, the CDMO aims to reduce absolute greenhouse gas emissions from Scope 1 and 2 by 58.8 percent (baseline 2021). These goals align with the Paris Agreement and represent one of the most rigorous standards for corporate climate action worldwide. The planned reductions will be achieved through a comprehensive mix of measures, including technical modernization of facilities and equipment, leveraging energy recovery potentials such as waste heat, and transitioning to lower-carbon energy sources–for example, replacing natural gas with biomethane.

“We are proud of the various steps we are taking to reduce our company’s carbon footprint,” states Managing Director Henryk Badack. “Both the validation by the SBTi and the Platinum rating from EcoVadis emphasize our strategic commitment to both people and planet and bring us one step closer to effective climate protection and to achieving overall sustainabilty goals."

Investing in renewable energy and nature restoration
Moving ahead, the family-owned company continues to invest in renewable energy projects. In 2025, the CDMO expanded its overall photovoltaic capacity, covering 22 percent of electricity needs of the Ravensburg Vetter West site. The company also began using biomethane, saving over 1,000 tons of CO₂ annually. Additional initiatives include removing sealed parking areas to create green spaces under photovoltaic installations—improving local microclimates and enabling natural rainwater infiltration.

“In partnership with a local partner supplying biomethane directly to our sites, we unite climate protection with regional value creation and energy security—while significantly reducing our environmental footprint,” says Gabriel Fischer, Team Lead Environment, Health & Safety / EHS Management Systems. “Alongside this, expanding our photovoltaic capacity and using state-of-the art technology like biomethane further demonstrates that sustainability and innovation can go hand in hand.”

  Find pictures and more materials here.  

About Vetter
Vetter is a leading Contract Development and Manufacturing Organization (CDMO) with headquarters in Ravensburg, Germany, and production facilities in Germany, Austria, and the US. As a global player, the independent pharmaceutical service provider is also present in the Asia-Pacific markets of Japan, China, South Korea and Singapore with sales locations. Around the world, small and large renowned pharma and biotech companies rely on the decades of experience, high quality, modern technologies, reliability, and commitment of its more than 7,300 employees. In close partnership with its customers, the Vetter team supplies patients all over the world with medicines, many of which are vital. The CDMO provides support from drug product development through clinical and commercial filling to a wide range of assembly and packaging services for vials, syringes, and cartridges. With innovative solutions, Vetter develops prefilled drug-delivery systems together with its customers to continuously improve patient safety, comfort, and compliance. The company is an industry pioneer in sustainability and a socially and ethically responsible corporate citizen. The CDMO is a member of the UN Global Compact and Science Based Target initiative (SBTi) and received gold status in the renowned EcoVadis ranking. Multiple awards such as the CDMO Leadership Awards, Frost & Sullivan Customer Value Leadership Award and the recognition as Best Managed Company emphasize Vetter’s commitment to sustainable business. Founded in Ravensburg in 1950, the company remains family-owned to this day. For more information, visit www.vetter-pharma.com and follow Vetter on LinkedIn.

Contact
Vetter Pharma International GmbH
Markus Kirchner
Corporate Spokesperson / Media Relations
Eywiesenstrasse 5
88212 Ravensburg
Germany
Phone: +49 (0)751-3700-3729
E-mail: PRnews@vetter-pharma.com

Joe Communications GmbH
Commercial register / Handelsregister Stuttgart HRB769013
Managing directors / Geschäftsführerinnen Lori Russo & Meike Grisson

 

Editor Details

Last Updated: 26-Jan-2026